Laser Forums

MCL31 Dermablate, der weltweit meistverkaufte fraktionierte Erbium-Laser wurde zur Behandlung von Hautproblemen wie epidermale und dermale Läsionen, Narben, oberflächliches und tiefes Skin Resurfacing entwickelt.

RE: Asclepion - MCL31 Dermablate

The erbium laser with fractional technology allows a safe and gentle skin rejuvenation. For more information please visit www.asclepion.com

RE: Asclepion - MCL31 Dermablate

Vascular treatment with the latest solid state laser from Asclepion. The video shows the complete treatment procedure. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO Yellow

The treatment of vascular lesions with the yellow or green solide state laser is a very safe and effective treatment. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO Yellow

The treatment of vascular lesions with the yellow or green solide state laser is a very safe and effective treatment. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO Green

Vascular treatment with the latest solid state laser from Asclepion. The video shows the complete treatment procedure. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO Green

Endovascular laser therapy with the latest diode laser from Asclepion. The video shows the complete treatment procedure. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO 940

Nail treatment with the infrared diode laser is fast and gentle. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO 980

Laser assisted lipolysis with the latest diode laser from Asclepion. The video shows the complete treatment procedure. For more information please visit www.asclepion.com

RE: Asclepion - QuadroStarPRO 980

Hair removal with a high power diode laser of MeDioStar NeXT PRO family guarantees a fast, safe and gentle treatment. For more information please visit www.asclepion.com

RE: Asclepion - MeDioStar NeXT PRO

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree